Macular thickness increases after cataract surgery

Article

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.

Dr M. Gharbiya et al., Department of Ophthalmology, Sapienza University, Umberto I Hospital, Rome, Italy, conducted a prospective, non-randomized, clinical study on 40 patients undergoing uneventful phacoemulsification with fellow eyes used as controls.

OCT measurements were gathered before surgery and postoperatively at day 1, week 1 and 2 and month 1, 2, 3 and 6. The retinal map was split into central point thickness (CPT), central 1 mm subfield (CSF) and two peripheral ring areas with diametres of 3 and 6 mm.

Retinal thickness change between the fellow and operated eyes were compared using unpaired t-test and correlations were assessed using the Spearman or Pearson analysis.

The results revealed a progressive significant increase in retinal thickness in the operated eyes compared to the fellow eyes, peaking at one month for the 3 mm and 6 mm areas and at 2 months for CPT and CSF.

At six months retinal thickness was still significantly thicker than fellow eyes, but only in the peripheral areas. No significant correlations were recorded between macular thickness changes and preoperative factors, intraoperative factors or BCVA change. The most significant findings was the regional pattern of retinal thickening with an early involvement of the parafoveal area.

Please click here to read the abstract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.